
|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Brands of the Year: Promise and Challengeover 8 years ago
Gauging the Collaborative Spirit in European Healthover 8 years ago
Gottlieb Tackles Drug Competition & Costsover 8 years ago
Deploying the Cloud in GxP Environmentsover 8 years ago
So Much Depends on the Physicianover 8 years ago
Bridging Science & Strategy: An Investor’s Eyeover 8 years ago
Patient Empowerment and the Future of Pharma Advertisingover 8 years ago
Closing Pharma’s Digital Divideover 8 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsover 8 years ago
The Total Care PackageAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5




